InspireMD, Inc.
NSPR
$2.59
-$0.01-0.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.70% | -45.88% | -36.44% | -24.23% | -7.71% |
| Total Depreciation and Amortization | 20.69% | 18.22% | 17.05% | 21.78% | 23.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 121.98% | 165.16% | 236.76% | 205.70% | 73.67% |
| Change in Net Operating Assets | 191.89% | -53.27% | 49.63% | -82.30% | -302.78% |
| Cash from Operations | -33.54% | -25.34% | -7.19% | -2.28% | -5.37% |
| Capital Expenditure | -267.98% | -400.38% | -150.90% | -19.52% | 19.45% |
| Sale of Property, Plant, and Equipment | -- | -66.67% | -66.67% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 189.32% | 147.54% | 214.47% | -213.19% | -276.39% |
| Cash from Investing | 178.55% | 135.85% | 205.51% | -221.37% | -290.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -53.76% | -57.66% | -57.66% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.25% | 100.00% | 100.00% | -3,210.71% | -3,210.71% |
| Cash from Financing | -50.84% | -55.00% | -52.30% | 26,910.00% | 26,910.00% |
| Foreign Exchange rate Adjustments | 187.93% | 133.85% | -122.73% | 72.60% | 55.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.22% | -80.02% | 226.86% | 244.57% | 167.93% |